Wednesday, 22 April 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 22 April 2026
News

From napkin to buyout in 10 years

Posted 22 April 2026 AM

US pharmaceutical consulting company IQVIA has bought 100 per cent of Sydney-based Lucid Health Consulting, bringing the Australian regulatory specialists into the IQVIA family of companies.

The deal unites Lucid's specialised expertise with IQVIA's global capabilities across pricing and market access strategy, real-world evidence, patient programs, and commercialisation planning. It lets Lucid offer an expanded range of solutions and services to its clients.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (6)

Sales & Customer Relations (15)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (3)

Other (9)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.